Previous studies showed that Annexin A2 is up-regulated on the surface of endothelial cells by high concentrations of glucose [41] and acts as an intermediate in diabetes-induced enhancement of plasmin activity in the aorta; and thus counteracts the hyper-thrombotic trend in vessels of diabetic patients [40], [41]. This evidence concerns the gene PLG and diabetes mellitus.